FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Nonopioid Alternatives Pamphlet
July 2, 2019

Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading


Telehealth
July 1, 2019

Click here for information on the new law that sets standards of practice and authorizes out-of-state health care practitioners to perform telehealth services for patients in Florida. Continue reading